Rheumatology Information Service Europe
Kineret FAQs: Properties and Pharmacokinetics
« Go back to Overview

Q1: What is Kineret®?
» Read answer

Q2: What is the pharmacokinetic profile of Kineret® (anakinra)?
» Read answer

Q3: Generally, what is the time to response with Kineret® therapy?
» Read answer

Q4: What is the plasma half-life of Kineret®?
» Read answer




« Go back to Overview

© 2008 Biovitrum AB (publ). All rights reserved.
This is a European website containing information about Kineret® (anakinra) and is intended for healthcare professionals within the European Union. The information on this site is not country-specific and may contain product-related information that is outside the approved product data sheet in the country in which you are located.
» Privacy Policy     » Terms of Use     » Contact Us